Odd Terje Brustugun

Bilde av Odd Terje Brustugun
English version of this page
Mobiltelefon 99723094
Brukernavn
Besøksadresse Onkologisk poliklinikk Drammen sykehus
Postadresse Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo

Publikasjoner

  • Sørensen, Jens Benn; Horvat, Pia; Rosenlund, Mats; Kejs, Anne Mette; Patel, Dony & Juarez-Garcia, Ariadna [Vis alle 12 forfattere av denne artikkelen] (2022). Initial treatment and survival in Danish patients diagnosed with non-small-cell lung cancer (2005-2015): SCAN-LEAF study. Future Oncology. ISSN 1479-6694. 18(2), s. 205–214. doi: 10.2217/fon-2021-0746.
  • Agbarya, Abed; Shalata, Walid; Addeo, Alfredo; Charpidou, Andriani; Cuppens, Kristof & Brustugun, Odd Terje [Vis alle 12 forfattere av denne artikkelen] (2022). Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment. Journal of Clinical Medicine. ISSN 2077-0383. 11(6). doi: 10.3390/jcm11061738.
  • Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; HORNSLIEN, KJERSTI & Madebo, Tesfaye [Vis alle 13 forfattere av denne artikkelen] (2022). Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer. Lung Cancer. ISSN 0169-5002. 166, s. 49–57. doi: 10.1016/j.lungcan.2022.02.002.
  • Nilssen, Yngvar; Brustugun, Odd Terje; Eriksen, Morten Tandberg; Guren, Marianne; Haug, Erik Skaaheim & Naume, Bjørn [Vis alle 8 forfattere av denne artikkelen] (2022). Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016. BMC Cancer. ISSN 1471-2407. doi: 10.1186/s12885-022-09306-9.
  • Ekman, Simon; Horvat, Pia; Rosenlund, Mats; Kejs, Anne Mette; Patel, Dony & Juarez-Garcia, Ariadna [Vis alle 11 forfattere av denne artikkelen] (2021). Epidemiology and Survival Outcomes for Patients With NSCLC in Scandinavia in the Preimmunotherapy Era: A SCAN-LEAF Retrospective Analysis From the I-O Optimise Initiative. JTO Clinical and Research Reports. 2(5). doi: 10.1016/j.jtocrr.2021.100165.
  • Frafjord, Astri; Buer, Linn; Hammarström, Clara Louise; Aamodt, Henrik; Woldbæk, Per R & Brustugun, Odd Terje [Vis alle 9 forfattere av denne artikkelen] (2021). The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed. Frontiers in Immunology. ISSN 1664-3224. 12:764596, s. 1–15. doi: 10.3389/fimmu.2021.764596. Fulltekst i vitenarkiv
  • Nilssen, Yngvar; Brustugun, Odd Terje & Møller, Bjørn (2021). Factors associated with emergency-related diagnosis, time to treatment and type of treatment in 5713 lung cancer patients. European Journal of Public Health. ISSN 1101-1262. 31(5), s. 967–974. doi: 10.1093/eurpub/ckab071.
  • Lehtiö, Janne; Arslan, Taner; Siavelis, Ioannis; Pan, Yanbo; Socciarelli, Fabio & Berkovska, Olena [Vis alle 29 forfattere av denne artikkelen] (2021). Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms. Cancer. ISSN 0008-543X. doi: 10.1038/s43018-021-00259-9.
  • Lærum, Dan; Brustugun, Odd Terje; Gallefoss, Frode; Falk, Ragnhild Sørum; Strand, Trond-Eirik & Fjellbirkeland, Lars (2021). Factors associated with delayed treatment initiation in an unselected cohort of patients with small-cell lung cancer. Cancer Treatment and Research Communications. ISSN 2468-2942. 29. doi: 10.1016/j.ctarc.2021.100477. Fulltekst i vitenarkiv
  • Bjaanæs, Maria Moksnes; Nilsen, Gro; Halvorsen, Ann Rita; Russnes, Hege Elisabeth Giercksky; Solberg, Steinar & Jørgensen, Lars [Vis alle 9 forfattere av denne artikkelen] (2021). Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors. BMC Cancer. ISSN 1471-2407. 21(1). doi: 10.1186/s12885-021-08811-7. Fulltekst i vitenarkiv
  • Eide, Inger Johanne & Brustugun, Odd Terje (2021). Lungekreft behandlet med reseptortyrosinkinasehemmer i utlandet. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 141(12), s. 1–4. doi: 10.4045/tidsskr.21.0147.
  • Eide, Inger Johanne; Grut, Harald; Helland, Åslaug; Ekman, Simon; Sørensen, Jens Benn & Hansen, Karin Holmskov [Vis alle 11 forfattere av denne artikkelen] (2021). Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study. Acta Oncologica. ISSN 0284-186X. doi: 10.1080/0284186X.2021.1973092. Fulltekst i vitenarkiv
  • Wahl, Sissel Gyrid Freim; Hong, Yan Dai; Emdal, Elisabeth Fritzke; Berg, Thomas; Halvorsen, Tarje Onsøien & Ottestad, Anine Larsen [Vis alle 14 forfattere av denne artikkelen] (2021). The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study. Cancers. ISSN 2072-6694. 13(17), s. 1–19. doi: 10.3390/cancers13174294. Fulltekst i vitenarkiv
  • Bugge, Christoffer; Brustugun, Odd Terje; Sæther, Erik Magnus & Kristiansen, Ivar Sønbø (2021). Phase- and gender-specific, lifetime, and future costs of cancer: A retrospective population-based registry study. Medicine. ISSN 0025-7974. 100(26), s. 1–8. doi: 10.1097/MD.0000000000026523.
  • Brustugun, Odd Terje; Nilssen, Yngvar & Eide, Inger Johanne (2021). Epidemiology and outcome of peritoneal and pleural mesothelioma subtypes in Norway. A 20 year nation-wide study. Acta Oncologica. ISSN 0284-186X. doi: 10.1080/0284186X.2021.1955971. Fulltekst i vitenarkiv
  • Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Brustugun, Odd; HORNSLIEN, KJERSTI & Madebo, Tesfaye [Vis alle 13 forfattere av denne artikkelen] (2021). High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. The Lancet Oncology. ISSN 1470-2045. 22(3), s. 321–331. doi: 10.1016/S1470-2045%2820%2930742-7.
  • Brustugun, Odd & Heggelund, Lars (2021). Koronavaksinering av kreftpasienter. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 141(3). doi: 10.4045/tidsskr.21.0026.
  • Popat, Sanjay; Brustugun, Odd; Cadranel, Jacques; Felip, Enriqueta; Garassino, Marina Chiara & Griesinger, Frank [Vis alle 12 forfattere av denne artikkelen] (2021). Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer. Lung Cancer. ISSN 0169-5002. 157, s. 9–16. doi: 10.1016/j.lungcan.2021.05.017. Fulltekst i vitenarkiv
  • Bugge, Christoffer; Sæther, Erik Magnus; Brustugun, Odd & Kristiansen, Ivar Sønbø (2021). Societal cost of cancer in Norway –Results of taking a broader cost perspective. Health Policy. ISSN 0168-8510. doi: 10.1016/j.healthpol.2021.05.008.
  • Berg, Janna; Ramberg, Christina; Haugstvedt, Jon Olav Sulheim; Bengtson, May-Bente; Gabrielsen, Anne Marie & Brustugun, Odd [Vis alle 8 forfattere av denne artikkelen] (2021). Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers. Frontiers in Oncology. ISSN 2234-943X. 11. doi: 10.3389/fonc.2021.674731. Fulltekst i vitenarkiv
  • Haakensen, Vilde Drageset; Khadse, Anand; Sandhu, Vandana; Halvorsen, Ann Rita; Solberg, Steinar & Jørgensen, Lars Hilmar [Vis alle 9 forfattere av denne artikkelen] (2020). Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy. International Journal of Cancer. ISSN 0020-7136. 147(10), s. 2957–2966. doi: 10.1002/ijc.33121. Fulltekst i vitenarkiv
  • Halvorsen, Ann Rita; Haugen, Mads Haugland; Øjlert, Åsa Kristina; Lund-Iversen, Marius; Jørgensen, Lars Hilmar & Solberg, Steinar [Vis alle 9 forfattere av denne artikkelen] (2020). Protein kinase C isozymes associated with relapse free survival in non-small cell lung cancer patients. Frontiers in Oncology. ISSN 2234-943X. 10:590755, s. 1–11. doi: 10.3389/fonc.2020.590755. Fulltekst i vitenarkiv
  • Yu, Hui; Brustugun, Odd Terje; Ekman, Simon; Botling, Johan; La Fleur, Linnea & Micke, Patrick [Vis alle 10 forfattere av denne artikkelen] (2020). Programmed cell death ligand 1 expression in resected non–small cell lung cancer. Clinical Lung Cancer. ISSN 1525-7304. s. 1–8. doi: 10.1016/j.cllc.2020.09.018.
  • Øjlert, Åsa Kristina; Nebdal, Daniel J.H.; Lund-Iversen, Marius; Ellefsen, Renée Åstrøm; Brustugun, Odd Terje & Gran, Jon Michael [Vis alle 8 forfattere av denne artikkelen] (2020). Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer–predictors of response and impact of previous radiotherapy. Acta Oncologica. ISSN 0284-186X. s. 1–9. doi: 10.1080/0284186X.2020.1854851. Fulltekst i vitenarkiv
  • Stankovic, Branislava; Aamodt, Henrik; Bjørhovde, Heidi Anine Korsmo; Müller, Elisabeth; Hammarström, Clara Louise & Brustugun, Odd Terje [Vis alle 9 forfattere av denne artikkelen] (2020). The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases. Scandinavian Journal of Immunology. ISSN 0300-9475. 92:e12893(2), s. 1–12. doi: 10.1111/sji.12893. Fulltekst i vitenarkiv
  • Halvorsen, Tarje Onsøien; Stokke, Kristin; Killingberg, Kristin Toftaker; Raj, Sunil Xavier; Sørhaug, Sveinung & Brustugun, Odd Terje [Vis alle 12 forfattere av denne artikkelen] (2020). Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Acta Oncologica. ISSN 0284-186X. doi: 10.1080/0284186X.2020.1778179.
  • Garon, Edward B.; Scagliotti, Giorgio Vittorio; Gautschi, Oliver; Reck, Martin; Thomas, Michael & Docampo, Lara Iglesias [Vis alle 20 forfattere av denne artikkelen] (2020). Exploratory analysis of front-line therapies in REVEL: A randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy. ESMO Open. ISSN 2059-7029. 5(1). doi: 10.1136/esmoopen-2019-000567.
  • Lærum, Dan; Brustugun, Odd Terje; Gallefoss, Frode; Falk, Ragnhild Sørum; Strand, Trond-Eirik & Fjellbirkeland, Lars (2020). Reduced delays in diagnostic pathways for non-small cell lung cancer after local and National initiatives. Cancer Treatment and Research Communications. ISSN 2468-2942. 23. doi: 10.1016/j.ctarc.2020.100168. Fulltekst i vitenarkiv
  • Eide, Inger Johanne; Helland, Åslaug; Ekman, Simon; Mellemgaard, Anders; Hansen, Karin Holmskov & Cicenas, Saulius [Vis alle 9 forfattere av denne artikkelen] (2020). Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study). Lung Cancer. ISSN 0169-5002. 143, s. 27–35. doi: 10.1016/j.lungcan.2020.03.009. Fulltekst i vitenarkiv
  • Frafjord, Astri; Skarshaug, Renate; Hammarström, Clara Louise; Stankovic, Branislava; Dorg, Linda Trobe & Aamodt, Henrik [Vis alle 11 forfattere av denne artikkelen] (2020). Antibody combinations for optimized staining of macrophages in human lung tumours. Scandinavian Journal of Immunology. ISSN 0300-9475. 92:e12889(1), s. 1–24. doi: 10.1111/sji.12889. Fulltekst i vitenarkiv
  • Nilssen, Yngvar; Brustugun, Odd Terje; Eriksen, Morten Tandberg; Haug, Erik Skaaheim; Naume, Bjørn & Møller, Bjørn (2020). Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016. BMC Cancer. ISSN 1471-2407. 20(1), s. 1–11. doi: 10.1186/s12885-020-06979-y. Fulltekst i vitenarkiv
  • Alcala, Nicolas; Leblay, N; Gabriel, AAG; Mangiante, L; Hervas, D & Giffon, T [Vis alle 70 forfattere av denne artikkelen] (2019). Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Nature Communications. ISSN 2041-1723. 10:3407, s. 1–21. doi: 10.1038/s41467-019-11276-9.
  • Menon, Usha; Vedsted, Peter; Zalounina Falborg, Alina; Jensen, Henry; Harrison, Samantha & Reguilon, Irene [Vis alle 26 forfattere av denne artikkelen] (2019). Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: Cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP). BMJ Open. ISSN 2044-6055. 9:e025895(11), s. 1–20. doi: 10.1136/bmjopen-2018-025895. Fulltekst i vitenarkiv
  • Halvorsen, Ann Rita; Aure, Miriam Ragle; Øjlert, Åsa Kristina; Brustugun, Odd Terje; Solberg, Steinar & Nebdal, Daniel J.H. [Vis alle 7 forfattere av denne artikkelen] (2019). Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC. Molecular Oncology. ISSN 1574-7891. doi: 10.1002/1878-0261.12571. Fulltekst i vitenarkiv
  • Øjlert, Åsa Kristina; Halvorsen, Ann Rita; Nebdal, Daniel J.H.; Lund-Iversen, Marius; Solberg, Steinar & Brustugun, Odd Terje [Vis alle 8 forfattere av denne artikkelen] (2019). The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery. Molecular Oncology. ISSN 1574-7891. 13(5), s. 1166–1179. doi: 10.1002/1878-0261.12475. Fulltekst i vitenarkiv
  • Solberg, Steinar; Nilssen, Yngvar; Brustugun, Odd Terje; Grimsrud, Tom Kristian; Haram, Per Magnus & Helbekkmo, Nina [Vis alle 15 forfattere av denne artikkelen] (2019). Increase in curative treatment and survival of lung cancer in Norway 2001-2016. European Journal of Epidemiology (EJE). ISSN 0393-2990. 34(10), s. 951–955. doi: 10.1007/s10654-019-00536-z. Fulltekst i vitenarkiv
  • Nilssen, Yngvar; Brustugun, Odd Terje; Eriksen, Morten Tandberg; Gulbrandsen, Johanne; Haug, Erik Skaaheim & Naume, Bjørn [Vis alle 7 forfattere av denne artikkelen] (2019). Decreasing waiting time for treatment before and during implementation of cancer patient pathways in Norway. Cancer Epidemiology. ISSN 1877-7821. 61, s. 59–69. doi: 10.1016/j.canep.2019.05.004. Fulltekst i vitenarkiv
  • Stankovic, Branislava; Bjørhovde, Heidi Anine Korsmo; Skarshaug, Renate; Aamodt, Henrik; Frafjord, Astri & Müller, Elisabeth [Vis alle 14 forfattere av denne artikkelen] (2018). Immune Cell Composition in Human Non-small Cell Lung Cancer. Frontiers in Immunology. ISSN 1664-3224. Feb(1), s. 1–21. doi: 10.3389/fimmu.2018.03101. Fulltekst i vitenarkiv
  • Halvorsen, Ann Rita; Sandhu, Vandana; Sprauten, Mette; Flote, Vidar Gordon; Kure, Elin Wenche Hegland & Brustugun, Odd Terje [Vis alle 7 forfattere av denne artikkelen] (2018). Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab. Acta Oncologica. ISSN 0284-186X. 57(9), s. 1225–1231. doi: 10.1080/0284186X.2018.1465585. Fulltekst i vitenarkiv
  • Bugge, Anders; Lund, May-Brith; Valberg, Morten; Brustugun, Odd Terje; Solberg, Steinar & Kongerud, Johny (2018). Cause-specific death after surgical resection for early-stage non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery. ISSN 1010-7940. 53(1), s. 221–227. doi: 10.1093/ejcts/ezx274.
  • George, Julie; Walter, Vonn; Peifer, Martin; Alexandrov, Ludmil B.; Seidel, Danila & Leenders, Frauke [Vis alle 62 forfattere av denne artikkelen] (2018). Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nature Communications. ISSN 2041-1723. 9:1048, s. 1–13. doi: 10.1038/s41467-018-03099-x. Fulltekst i vitenarkiv
  • Berg, Janna; Halvorsen, Ann Rita; Bengtson, May-Bente; Tasken, Kristin Austlid; Mælandsmo, Gunhild Mari & Yndestad, Arne [Vis alle 11 forfattere av denne artikkelen] (2018). Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease. BMC Cancer. ISSN 1471-2407. 18(1). doi: 10.1186/s12885-018-4659-0.
  • Brustugun, Odd Terje; Grønberg, Bjørn Henning; Fjellbirkeland, Lars; Helbekkmo, Nina; Aanerud, Marianne & Grimsrud, Tom Kristian [Vis alle 11 forfattere av denne artikkelen] (2018). Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016. Lung Cancer. ISSN 0169-5002. 122, s. 138–145. doi: 10.1016/j.lungcan.2018.06.003. Fulltekst i vitenarkiv
  • Eide, Hanne Astrid; Knudtsen, Ingerid Skjei; Sandhu, Vandana; Løndalen, Ayca; Halvorsen, Ann Rita & Abravan, Azadeh [Vis alle 12 forfattere av denne artikkelen] (2018). Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy. Advances in Radiation Oncology. ISSN 2452-1094. 3(2), s. 130–138. doi: 10.1016/j.adro.2017.12.007. Fulltekst i vitenarkiv
  • Lund-Iversen, Marius; Scott, Helge; Strøm, Erik Heyerdahl; Theiss, Noah; Brustugun, Odd Terje & Grønberg, Bjørn Henning (2018). Expression of estrogen receptor-α and survival in advanced-stage non-small cell lung cancer. Anticancer Research. ISSN 0250-7005. 38(4), s. 2261–2269. doi: 10.21873/anticanres.12470. Fulltekst i vitenarkiv
  • Valan, Christine Damgaard; Slagsvold, Jens Erik; Halvorsen, Tarje Onsøien; Herje, Martin; Bremnes, Roy M. & Brunsvig, Paal Fr. [Vis alle 11 forfattere av denne artikkelen] (2018). Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement. Anticancer Research. ISSN 0250-7005. 38(2), s. 871–876. doi: 10.21873/anticanres.12296. Fulltekst i vitenarkiv
  • Mcgowan, Marc Kevin; Kleinberg, Lilach; Halvorsen, Ann Rita; Helland, Åslaug & Brustugun, Odd Terje (2017). NSCLC depend upon YAP expression and nuclear localization after acquiring resistance to EGFR inhibitors. Genes & cancer. ISSN 1947-6019. 8(3-4), s. 497–504. doi: 10.18632/genesandcancer.136. Fulltekst i vitenarkiv
  • Meyer, Mathias; Vliegenthart, Rozemarijn; Henzler, Thomas; Buergy, Daniel; Giordano, Frank A. & Kostrzewa, Michael [Vis alle 29 forfattere av denne artikkelen] (2017). Management of progressive pulmonary nodules found during and outside of CT lung cancer screening studies. Journal of Thoracic Oncology. ISSN 1556-0864. 12(12), s. 1755–1765. doi: 10.1016/j.jtho.2017.09.1956.
  • Pedersen, Jesper Holst; Sørensen, Jens Benn; Saghir, Zaigham; Fløtten, Øystein; Brustugun, Odd Terje & Ashraf, Haseem [Vis alle 15 forfattere av denne artikkelen] (2017). Implementation of lung cancer CT screening in the Nordic countries. Acta Oncologica. ISSN 0284-186X. 56(10), s. 1249–1257. doi: 10.1080/0284186X.2017.1329592.
  • Helland, Åslaug; Brustugun, Odd Terje; Nakken, Sigve; Halvorsen, Ann Rita; Dønnem, Tom & Bremnes, Roy M. [Vis alle 15 forfattere av denne artikkelen] (2017). High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival. International Journal of Cancer. ISSN 0020-7136. 141(1), s. 184–190. doi: 10.1002/ijc.30726. Fulltekst i vitenarkiv
  • Brustugun, Odd Terje; Sprauten, Mette & Helland, Åslaug (2017). Real-world data on nivolumab treatment of non-small cell lung cancer. Acta Oncologica. ISSN 0284-186X. 56(3), s. 438–440. doi: 10.1080/0284186X.2016.1253865.
  • Manegold, Christian; Dingemans, Anne-Marie C; Gray, Jhanelle E; Nakagawa, Kazuhiko; Nicolson, Marianne & Peters, Solange [Vis alle 27 forfattere av denne artikkelen] (2016). The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC. Journal of Thoracic Oncology. ISSN 1556-0864. 12(2), s. 194–207. doi: 10.1016/j.jtho.2016.10.003.
  • Weischenfeldt, Joachim; Dubash, Taronish; Drainas, Alexandros P.; Mardin, Balca R.; Chen, Yuanyuan & Stütz, Adrian M. [Vis alle 32 forfattere av denne artikkelen] (2016). Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. Nature Genetics. ISSN 1061-4036. 49(1), s. 65–74. doi: 10.1038/ng.3722.
  • Mcgowan, Marc Kevin; Hoven, Aleksandra Silye; Lund-Iversen, Marius; Solberg, Steinar; Helland, Åslaug & Hirsch, Fred R [Vis alle 7 forfattere av denne artikkelen] (2016). PIK3CA mutations as prognostic factor in squamous cell lung carcinoma. Lung Cancer. ISSN 0169-5002. 103, s. 52–57. doi: 10.1016/j.lungcan.2016.11.018.
  • Nyman, Jan; Hallqvist, Andreas; Lund, Jo-Åsmund; Brustugun, Odd Terje; Bergman, Bengt & Bergström, Per [Vis alle 10 forfattere av denne artikkelen] (2016). SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiotherapy and Oncology. ISSN 0167-8140. 121(1), s. 1–8. doi: 10.1016/j.radonc.2016.08.015.
  • Halvorsen, Tarje Onsøien; Herje, Martin; Levin, Nina; Bremnes, Roy M.; Brustugun, Odd Terje & Fløtten, Øystein [Vis alle 9 forfattere av denne artikkelen] (2016). Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer. Lung Cancer. ISSN 0169-5002. 102, s. 9–14. doi: 10.1016/j.lungcan.2016.10.003. Fulltekst i vitenarkiv
  • Eide, Hanne Astrid; Halvorsen, Ann Rita; Sandhu, Vandana; Fåne, Anne; Berg, Janna & Haakensen, Vilde Drageset [Vis alle 11 forfattere av denne artikkelen] (2016). Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease. Clinical & translational immunology. ISSN 2050-0068. 5. doi: 10.1038/cti.2016.65. Fulltekst i vitenarkiv
  • Halvorsen, Tarje Onsøien; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr. & Aasebø, Ulf [Vis alle 9 forfattere av denne artikkelen] (2016). Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer. Acta Oncologica. ISSN 0284-186X. 55(11), s. 1349–1354. doi: 10.1080/0284186X.2016.1201216. Fulltekst i vitenarkiv
  • Halvorsen, Ann Rita; Bjaanæs, Maria Moksnes; LeBlanc, Marissa; Holm, Are Martin; Bolstad, Nils & Rubio, Luis [Vis alle 12 forfattere av denne artikkelen] (2016). A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer. OncoTarget. ISSN 1949-2553. 7(24), s. 37250–37259. doi: 10.18632/oncotarget.9363.
  • Rud, Ane Kristine Kongsgaard; Pedersen, Kjetil Boye; Fodstad, Øystein; Juell, Siri; Jørgensen, Lars Hilmar & Solberg, Steinar [Vis alle 9 forfattere av denne artikkelen] (2016). Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer. Diagnostic Pathology. ISSN 1746-1596. 11(50). doi: 10.1186/s13000-016-0504-4. Fulltekst i vitenarkiv
  • Joly-Battaglini, Albane; Hammarström, Clara Louise; Stankovic, Branislava; Aamodt, Henrik; Stjärne, Johan Folke Håkan & Brustugun, Odd Terje [Vis alle 9 forfattere av denne artikkelen] (2016). Rituximab efficiently depletes B cells in lung tumors and normal lung tissue. F1000. ISSN 1759-796X. 5. doi: 10.12688/f1000research.7599.1.
  • Halvorsen, Ann Rita; Silwal-Pandit, Laxmi; Meza, Leonardo Zepeda; Vodak, Daniel; Vu, Phuong Ngoc Thi & Sagerup, Camilla Maria Troøien [Vis alle 11 forfattere av denne artikkelen] (2016). TP53 mutation spectrum in smokers and never smoking lung cancer patients. Frontiers in Genetics. ISSN 1664-8021. 7(MAY). doi: 10.3389/fgene.2016.00085.
  • Eide, Hanne Astrid; Halvorsen, Ann Rita; Bjaanæs, Maria Moksnes; Piri, Hossein; Holm, Ruth & Solberg, Steinar [Vis alle 10 forfattere av denne artikkelen] (2016). The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma-differences in histological subtypes. BMC Cancer. ISSN 1471-2407. 16(1). doi: 10.1186/s12885-016-2104-9.
  • Bjaanæs, Maria Moksnes; Fleischer, Thomas; Halvorsen, Ann Rita; Daunay, Antoine; Busato, Florence & Solberg, Steinar [Vis alle 14 forfattere av denne artikkelen] (2016). Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis. Molecular Oncology. ISSN 1574-7891. 10(2), s. 330–343. doi: 10.1016/j.molonc.2015.10.021.
  • Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr. & Aasebø, Ulf [Vis alle 12 forfattere av denne artikkelen] (2016). Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer. Acta Oncologica. ISSN 0284-186X. 55(5), s. 591–597. doi: 10.3109/0284186X.2015.1092584. Fulltekst i vitenarkiv
  • Dønnem, Tom; Kilvær, Thomas Karsten; Andersen, Sigve; Richardsen, Elin; Paulsen, Erna-Elise & Hald, Sigurd [Vis alle 21 forfattere av denne artikkelen] (2016). Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Annals of Oncology. ISSN 0923-7534. 27(2), s. 225–232. doi: 10.1093/annonc/mdv560.
  • Nilssen, Yngvar; Strand, Trond-Eirik; Fjellbirkeland, Lars; Bartnes, Kristian; Brustugun, Odd Terje & O'Connell, Dianne L [Vis alle 8 forfattere av denne artikkelen] (2016). Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage. International Journal of Cancer. ISSN 0020-7136. 138(6), s. 1350–1360. doi: 10.1002/ijc.29875.
  • Berg, Janna; Fjellbirkeland, Lars; Suhrke, Pål; Jebsen, Peter Wilhelm; Lund-Iversen, Marius & Kleinberg, Lilach [Vis alle 9 forfattere av denne artikkelen] (2016). EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust. Acta Oncologica. ISSN 0284-186X. 55(2), s. 149–155. doi: 10.3109/0284186X.2015.1062537.
  • Bjaanæs, Maria Moksnes; Nilsen, Gro; Solberg, Steinar; Brustugun, Odd Terje; Lingjærde, Ole Christian & Helland, Åslaug (2015). Whole-genome copy number analyses of NSCLC tumors reveal aberrations associated with EGFR mutations and may have prognostic impact. Journal of Thoracic Oncology. ISSN 1556-0864. 10(9), s. S581–S582.
  • Lund-Iversen, Marius; Kotanska-Grøholt, Krystyna; Helland, Åslaug; Borgen, Elin & Brustugun, Odd Terje (2015). NUT expression in primary lung tumours. Diagnostic Pathology. ISSN 1746-1596. 10:156. doi: 10.1186/s13000-015-0395-9.
  • Fernandez-Cuesta, Lynnette; Sun, Ruping; Menon, Roopika; George, Julie; Lorenz, Susanne & Meza, Leonardo Zepeda [Vis alle 40 forfattere av denne artikkelen] (2015). Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data. Genome Biology. ISSN 1465-6906. 16:7. doi: 10.1186/s13059-014-0558-0.
  • George, Julie; Lim, Jing Shan; Jang, Se Jin; Cun, Yupeng; Ozretić, Luka & Kong, Gu [Vis alle 96 forfattere av denne artikkelen] (2015). Comprehensive genomic profiles of small cell lung cancer. Nature. ISSN 0028-0836. 524(7563), s. 47–53. doi: 10.1038/nature14664.
  • Brustugun, Odd Terje (2015). Hypoxia as a Cause of Treatment Failure in Non–Small Cell Carcinoma of the Lung. Seminars in Radiation Oncology. ISSN 1053-4296. 25(2), s. 87–92. doi: 10.1016/j.semradonc.2014.11.006.
  • Dønnem, Tom; Hald, Sigurd; Paulsen, Erna-Elise; Richardsen, Elin; Al-Saad, Samer & Kilvær, Thomas Karsten [Vis alle 20 forfattere av denne artikkelen] (2015). Stromal CD8+ T-cell density - A promising supplement to TNM staging in non-small cell lung cancer. Clinical Cancer Research. ISSN 1078-0432. 21(11), s. 2635–2643. doi: 10.1158/1078-0432.CCR-14-1905.
  • Fernandez-Cuesta, Lynnette; Peifer, Martin; Lu, Xin; Sun, Ruping; Ozretic, Luka & Seidel, Danila [Vis alle 46 forfattere av denne artikkelen] (2014). Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nature Communications. ISSN 2041-1723. 27(5). doi: 10.1038/ncomms4518.
  • Brustugun, Odd Terje; Møller, Bjørn & Helland, Åslaug (2014). Years of life lost as a measure of cancer burden on a national level. British Journal of Cancer. ISSN 0007-0920. 111(5), s. 1014–1020. doi: 10.1038/bjc.2014.364.
  • Bjaanæs, Maria Moksnes; Halvorsen, Ann Rita; Solberg, Steinar; Jørgensen, Lars Hilmar; Dragani, Tomasso A. & Galvan, Antonella [Vis alle 13 forfattere av denne artikkelen] (2014). Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas. International Journal of Cancer. ISSN 0020-7136. 135(8), s. 1812–1821. doi: 10.1002/ijc.28828.
  • Brustugun, Odd Terje; Khattak, Asma Malik; Trømborg, Anette Kjoshagen; Beigi, Marzieh; Beiske, Klaus & Lund-Iversen, Marius [Vis alle 7 forfattere av denne artikkelen] (2014). BRAF-mutations in non-small cell lung cancer. Lung Cancer. ISSN 0169-5002. 84(1), s. 36–38. doi: 10.1016/j.lungcan.2014.01.023.
  • Sagerup, Camilla Maria Troøien; Nymoen, Dag Andre; Halvorsen, Ann Rita; Lund-Iversen, Marius; Helland, Åslaug & Brustugun, Odd Terje (2014). Human papilloma virus detection and typing in 334 lung cancer patients. Acta Oncologica. ISSN 0284-186X. 53(7), s. 952–957. doi: 10.3109/0284186X.2013.879608.
  • Brustugun, Odd Terje & Helland, Åslaug (2014). Rapid reduction in the incidence of cancer of unknown primary. A population-based study. Acta Oncologica. ISSN 0284-186X. 53(1), s. 134–137. doi: 10.3109/0284186X.2013.783230.
  • Rud, Ane Kristine Kongsgaard; Pedersen, Kjetil Boye; Øijordsbakken, Miriam; Lund-Iversen, Marius; Halvorsen, Ann Rita & Solberg, Steinar [Vis alle 10 forfattere av denne artikkelen] (2013). Osteopontin is a prognostic biomarker in non-small cell lung cancer. BMC Cancer. ISSN 1471-2407. 13. doi: 10.1186/1471-2407-13-540. Fulltekst i vitenarkiv
  • Seidel, Danila; Zander, Thomas; Heukamp, Lukas C; Peifer, Martin; Bos, Marc & Fernandez-Cuesta, Lynnette [Vis alle 134 forfattere av denne artikkelen] (2013). A Genomics-Based Classification of Human Lung Tumors. Science Translational Medicine. ISSN 1946-6234. 5(209). doi: 10.1126/scitranslmed.3006802.
  • Nordgård, Oddmund; Dhillon, Gurpartap Singh; Solberg, Steinar; Jørgensen, Lars Hilmar; Halvorsen, Ann Rita & Smaaland, Rune [Vis alle 8 forfattere av denne artikkelen] (2013). Novel Molecular Tumor Cell Markers in Regional Lymph Nodes and Blood Samples from Patients Undergoing Surgery for Non-Small Cell Lung Cancer. PLOS ONE. ISSN 1932-6203. 8(5). doi: 10.1371/journal.pone.0062153.

Se alle arbeider i Cristin

  • Brustugun, Odd Terje; Sørhaug, Sveinung; Grønberg, Bjørn Henning; Aanerud, Marianne; Al-Zubaydi, Mohammed Modar & Fjellbirkeland, Lars [Vis alle 13 forfattere av denne artikkelen] (2020). Lungekreft: Forbedret prognose gir kapasitetsutfordringer. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 140(5). doi: 10.4045/tidsskr.20.0014.
  • Sørensen, J.B.; Ekman, S.; Brustugun, Odd Terje; Horvat, P.; Patel, D. & Rosenlund, M. [Vis alle 13 forfattere av denne artikkelen] (2019). Evolution of overall survival (OS) in patients (pts) with incident NSCLC in Denmark and Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative. Annals of Oncology. ISSN 0923-7534. 30, s. ii16–ii17. doi: 10.1093/annonc/mdz070.004.
  • Ekman, S.; Sørensen, J.B.; Brustugun, Odd Terje; Horvat, P.; Patel, D. & Rosenlund, M. [Vis alle 13 forfattere av denne artikkelen] (2019). Treatment (Tx) patterns and overall survival (OS) in patients (pts) with NSCLC in Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative. Annals of Oncology. ISSN 0923-7534. 30, s. ii17–ii17. doi: 10.1093/annonc/mdz070.005.
  • Berg, Janna; Lindberg, Morten; Bengtson, May-Bente; Brustugun, Odd Terje & Helland, Åslaug (2019). The Neutrophil and Platelet to Lymphocyte Ratios and Glasgow Prognostic Score as a Predictor for Relapse After Stereotactic Radiation for Lung Cancer. Journal of Thoracic Oncology. ISSN 1556-0864. 14. doi: 10.1016/j.jtho.2019.08.2457.
  • Brustugun, Odd Terje (2019). A NOTCH added to metabolomics. British Journal of Cancer. ISSN 0007-0920. 121, s. 3–4. doi: 10.1038/s41416-019-0463-0.
  • Knudtsen, Ingerid Søberg Skjei; Eide, Hanne Astrid; Løndalen, Ayca; Abravan, Azadeh; Bogsrud, Trond & Sprauten, Mette [Vis alle 9 forfattere av denne artikkelen] (2017). 18FDG-PET/CT for assessing short-term therapy response of advanced non-small cell lung cancer patients.
  • Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr. & Bremnes, Roy M. [Vis alle 8 forfattere av denne artikkelen] (2015). Associations between Comorbidity, Treatment Toxicity and Overall Survival in Limited Disease Small-Cell Lung Cancer (LD-SCLC). Journal of Thoracic Oncology. ISSN 1556-0864. 10(9).
  • Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Levin, Nina; Bremnes, Roy M.; Brunsvig, Paal Fr. & Fløtten, Øystein [Vis alle 9 forfattere av denne artikkelen] (2015). Survival of patients with N3 lymph node disease in a cohort with limited disease small-cell lung cancer receiving concurrent chemoradiotherapy. Journal of Thoracic Oncology. ISSN 1556-0864. 10(9).
  • Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Levin, Nina; Bremnes, Roy M.; Brunsvig, Paal Fr. & Brustugun, Odd Terje [Vis alle 8 forfattere av denne artikkelen] (2015). Survival of patients with N3 lymph node disease in a cohort with limited disease small-cell lung cancer receiving concurrent chemoradiotherapy.
  • Grønberg, Bjørn Henning; Levin, Nina; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje & Brunsvig, Paal Fr. [Vis alle 9 forfattere av denne artikkelen] (2015). Reduction in tumor size after the first course of cisplatin/etoposide (PE) in limited disease small-cell lung cancer (LD SCLC). Journal of Clinical Oncology. ISSN 0732-183X. 33.
  • Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr. & Aasebø, Ulf [Vis alle 9 forfattere av denne artikkelen] (2015). Association between comorbidity, treatment toxicity and overall survival in limited disease small-cell lung cancer.
  • Brustugun, Odd Terje (2015). Re: En rivende utvikling? Tidsskrift for Den norske legeforening. ISSN 0029-2001. 135(5), s. 413–414. doi: 10.4045/tidsskr.15.0208.
  • Abravan, Azadeh; Knudtsen, Ingerid Skjei; Eide, Hanne; Brustugun, Odd Terje; Helland, Åslaug & Malinen, Eirik (2015). FDG-PET response in the normal lung for lung cancer patients receiving fractionated radiotherapy and erlotinib. Radiotherapy and Oncology. ISSN 0167-8140. 115, s. s634–s634. doi: 10.1016/S0167-8140%2815%2941159-4.
  • Abravan, Azadeh; Knudtsen, Ingerid Skjei; Eide, Hanne Astrid; Brustugun, Odd Terje; Helland, Åslaug & Malinen, Eirik (2014). Assessing glycolytic response in normal tissues following fractionated radiotherapy.
  • Knudtsen, Ingerid Skjei; Eide, Hanne; Løndalen, Ayca Muftuler; Bogsrud, Trond Velde; Brustugun, Odd Terje & Helland, Åslaug [Vis alle 7 forfattere av denne artikkelen] (2014). 18FDG-PET/CT evaluation of non-small cell lung cancer patients receiving radiotherapy and erlotinib. Radiotherapy and Oncology. ISSN 0167-8140. 111, s. 667–667.
  • Abravan, Azadeh; Knudtsen, Ingerid Skjei; Eide, Hanne; Brustugun, Odd Terje; Helland, Åslaug & Malinen, Eirik (2014). Monitoring changes in lung glucose metabolism for patients with lung cancer receiving thoracic irradiation. Radiotherapy and Oncology. ISSN 0167-8140. 111, s. 664–664.
  • Mynarek, Georg; Aaløkken, Trond Mogens; Martinsen, Anne Catrine Trægde & Brustugun, Odd Terje (2014). Re: Begrenset malignitetsutredning ved idiopatisk venøs trombose :. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 134(8), s. 814–815. doi: 10.4045/tidsskr.14.0468.

Se alle arbeider i Cristin

Publisert 11. nov. 2021 12:42 - Sist endret 28. nov. 2021 18:06